Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | APOBEC3G |
| Upstream (Parents) |
|---|
| (<<) BTN3A3 → APOBEC3G |
| (<<) MAP7 → APOBEC3G |
| (<<) HLA-DPA1 → APOBEC3G |
| (<<) TRIM22 → APOBEC3G |
| (<<) HLA-DMA → APOBEC3G |
| Downstream (Children) |
|---|
| APOBEC3G → PRKACB (>>) |
| APOBEC3G → CRTAM (>>) |
| APOBEC3G → HLA-DOB (>>) |
| APOBEC3G → HLA-DPA1 (>>) |
| APOBEC3G → COL4A5 (>>) |
| APOBEC3G → POU4F2 (>>) |
| APOBEC3G → PTGER2 (>>) |
| APOBEC3G → IFNG (>>) |
| APOBEC3G → LRMP (>>) |
| APOBEC3G → ACAP1 (>>) |
| APOBEC3G → KLRK1 (>>) |
| APOBEC3G → DUSP26 (>>) |
| APOBEC3G → SDHB (>>) |
| APOBEC3G → KIAA1466 (>>) |
| APOBEC3G → IL15 (>>) |
| APOBEC3G → GLRX (>>) |
| APOBEC3G → TREX2 (>>) |
